Biodexa Strengthens Management Team - Appointment of Dr Gary A. Shangold as Chief Medical Officer
22 janv. 2025 08h30 HE
|
Biodexa Pharmaceuticals PLC
January 22, 2025 Biodexa Strengthens Management Team Appointment of Dr Gary A. Shangold as Chief Medical Officer Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a...
Result of General Meeting
22 nov. 2024 08h30 HE
|
Biodexa Pharmaceuticals PLC
November 22, 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Result of General Meeting Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (NASDAQ: BDRX), a clinical stage...